Telix Pharmaceuticals LimitedASX: TLX

Telix Reports Third Quarter 2026 Financial Performance

· Issued by Telix Pharmaceuticals Limited via ASX

Filed with ASX ·

Telix Pharmaceuticals Limited ACN 616 620 369 55 Flemington Road North Melbourne Victoria, 3051 Australia ASX ANNOUNCEMENT Telix Reports Third Quarter 2026 Financial Performance Melbourne (Australia) and Indianapolis, IN (U.S.) – October 21, 2026. Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:...

View Attachment

6ix is reading this filing.

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

All Telix Pharmaceuticals news releases